Malignant Neoplasms of Digestive Organs: Clinical Trials

2 trials for Malignant Neoplasms of Digestive Organs, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow Malignant Neoplasms of Digestive Organs: new trials by email Literature Review of Malignant Neoplasms of Digestive Organs trials Research Report on Malignant Neoplasms of Digestive Organs

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
LM-302, Toripalimab, Capecitabine - Malignant Neoplasms of Digestive Organs
Phase 2RecruitingLaNova Medicines Zhejiang Co., Ltd.6322023-07-272026-10-19
Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer
Durvalumab, Trametinib - Malignant Neoplasms of Digestive Organs, Colorectal Cancer
Phase 2CompletedM.D. Anderson Cancer Center292018-03-212023-06-15

Narrower conditions

Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)

Broader conditions

Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Rectal Diseases (1)

Interventions

Capecitabine (1)  ·  Gemcitabine (1)  ·  Nivolumab (1)  ·  Tegafur (1)  ·  anlotinib (1)  ·  apatinib (1)  ·  durvalumab (1)  ·  gimeracil (1)  ·  potassium oxonate (1)  ·  tislelizumab (1)  ·  toripalimab (1)  ·  trametinib (1)

Sponsors

LaNova Medicines Zhejiang Co., Ltd. (1)  ·  M.D. Anderson Cancer Center (1)

Countries

China (1)  ·  United States (1)

Top investigators

Aiping Zhou (1)  ·  Chunmei Bai (1)  ·  Deliang Fu (1)  ·  Haijiao Yan (1)  ·  Haiping Jiang (1)  ·  Jieer Ying (1)  ·  Jin Li (1)  ·  Jing Dai (1)  ·  Jun Zhou (1)  ·  Kuirong Jiang (1)  ·  Liang Liu (1)  ·  Lixin Wan (1)  ·  Michael Overman, MD (1)  ·  Mingzhu Huang (1)  ·  Ning Wu (1)

Results publications

PMID 36007963